CFH gene therapy (Disc Medicine/StrideBio)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameCFH gene therapy (Disc Medicine/StrideBio)
Drug Alias Nameadeno-associated viral vector based gene therapy (Disc Medicine/StrideBio)
ClassificationBiologics
Mechanisms of ActionComplement factor H stimulants
TargetsComplement factor H
Therapy Area/IndicationsKidney DiseasesGeographic Atrophy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDisc Medicine Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesStridebio IncDisc Medicine Inc
Active IndicationsN/A
Inactive IndicationsKidney DiseasesGeographic Atrophy

Other Information

ATC CodeN/A
Related LinksN/A